P2X7R antagonism suppresses long-lasting brain hyperexcitability following traumatic brain injury in mice.

IF 13.3 1区 医学 Q1 MEDICINE, RESEARCH & EXPERIMENTAL Theranostics Pub Date : 2025-01-27 eCollection Date: 2025-01-01 DOI:10.7150/thno.97254
Mariana Alves, Laura de Diego-Garcia, Gloria Vegliante, Oscar Moreno, Beatriz Gil, Pedro Ramos-Cabrer, Meghma Mitra, Ana Fernandez Martin, Aida Menéndez-Méndez, Yitao Wang, Nathan Ryzewski Strogulski, Meng-Juan Sun, Ciara Melia, Giorgia Conte, Sandra Plaza-García, Igor Khalin, Xinchen Teng, Nikolaus Plesnila, Bert Klebl, Klaus Dinkel, Michael Hamacher, Anindya Bhattacharya, Marc Ceusters, James Palmer, David J Loane, Jordi Llop, David C Henshall, Tobias Engel
{"title":"P2X7R antagonism suppresses long-lasting brain hyperexcitability following traumatic brain injury in mice.","authors":"Mariana Alves, Laura de Diego-Garcia, Gloria Vegliante, Oscar Moreno, Beatriz Gil, Pedro Ramos-Cabrer, Meghma Mitra, Ana Fernandez Martin, Aida Menéndez-Méndez, Yitao Wang, Nathan Ryzewski Strogulski, Meng-Juan Sun, Ciara Melia, Giorgia Conte, Sandra Plaza-García, Igor Khalin, Xinchen Teng, Nikolaus Plesnila, Bert Klebl, Klaus Dinkel, Michael Hamacher, Anindya Bhattacharya, Marc Ceusters, James Palmer, David J Loane, Jordi Llop, David C Henshall, Tobias Engel","doi":"10.7150/thno.97254","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> Post-traumatic epilepsy (PTE) is one of the most common life-quality reducing consequences of traumatic brain injury (TBI). However, to date there are no pharmacological approaches to predict or to prevent the development of PTE. The P2X7 receptor (P2X7R) is a cationic ATP-dependent membrane channel that is expressed throughout the brain. While increasing evidence suggests a role for the P2X7R during seizures and epilepsy, it is unclear if changes in P2X7R expression can predict TBI-induced epilepsy development, and whether P2X7R antagonism can protect against long-lasting brain hyperexcitability caused by TBI. <b>Methods:</b> TBI was induced in adult male mice using the controlled cortical impact model (CCI). To test the anti-epileptogenic effects of P2X7R antagonism, mice were treated with brain-penetrant P2X7R antagonists JNJ-54175446 (30 mg/kg) or AFC-5128 (30 mg/kg) for 7 days post-CCI. The cell-type specific effects of P2X7Rs on TBI-induced hyperexcitability were analyzed in mice lacking exon 2 of the <i>P2rx7</i> gene selectively in microglia (<i>P2rx7</i>:<i>Cx3cr1</i>-Cre). Static positron emission tomography (PET) via an intravenous injection of the P2X7R radioligand <sup>18</sup>F-JNJ-64413739 and magnetic resonance imaging (MRI) were conducted twice during the first- and third-week post-injury. <b>Results:</b> Following TBI, while there were no obvious changes in P2X7R protein levels in the ipsilateral hippocampus post-injury, there was a delayed increase in P2X7R protein levels in the ipsilateral cortex at 3 months post-injury. Treatment with P2X7R antagonists shortly after TBI reduced long-lasting brain hyperexcitability, reduced cortical contusion volume, and normalized injury-induced hyperactivity to control sham-levels at 3 weeks post-TBI. Notably, mice lacking <i>P2rx7</i> in microglia had an increased seizure threshold after TBI, suggesting that P2X7R contributed to brain hyperexcitability via its effects on microglia. Finally, P2X7R radioligand uptake after TBI correlated with seizure threshold at 3 weeks post-injury. <b>Conclusions:</b> Our results demonstrate the antiepileptogenic potential of P2X7R antagonism to prevent TBI-induced epilepsy and indicate that P2X7R-based PET imaging may be a useful diagnostic tool to identify people at risk of developing PTE.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"15 4","pages":"1399-1419"},"PeriodicalIF":13.3000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11780721/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Theranostics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/thno.97254","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Post-traumatic epilepsy (PTE) is one of the most common life-quality reducing consequences of traumatic brain injury (TBI). However, to date there are no pharmacological approaches to predict or to prevent the development of PTE. The P2X7 receptor (P2X7R) is a cationic ATP-dependent membrane channel that is expressed throughout the brain. While increasing evidence suggests a role for the P2X7R during seizures and epilepsy, it is unclear if changes in P2X7R expression can predict TBI-induced epilepsy development, and whether P2X7R antagonism can protect against long-lasting brain hyperexcitability caused by TBI. Methods: TBI was induced in adult male mice using the controlled cortical impact model (CCI). To test the anti-epileptogenic effects of P2X7R antagonism, mice were treated with brain-penetrant P2X7R antagonists JNJ-54175446 (30 mg/kg) or AFC-5128 (30 mg/kg) for 7 days post-CCI. The cell-type specific effects of P2X7Rs on TBI-induced hyperexcitability were analyzed in mice lacking exon 2 of the P2rx7 gene selectively in microglia (P2rx7:Cx3cr1-Cre). Static positron emission tomography (PET) via an intravenous injection of the P2X7R radioligand 18F-JNJ-64413739 and magnetic resonance imaging (MRI) were conducted twice during the first- and third-week post-injury. Results: Following TBI, while there were no obvious changes in P2X7R protein levels in the ipsilateral hippocampus post-injury, there was a delayed increase in P2X7R protein levels in the ipsilateral cortex at 3 months post-injury. Treatment with P2X7R antagonists shortly after TBI reduced long-lasting brain hyperexcitability, reduced cortical contusion volume, and normalized injury-induced hyperactivity to control sham-levels at 3 weeks post-TBI. Notably, mice lacking P2rx7 in microglia had an increased seizure threshold after TBI, suggesting that P2X7R contributed to brain hyperexcitability via its effects on microglia. Finally, P2X7R radioligand uptake after TBI correlated with seizure threshold at 3 weeks post-injury. Conclusions: Our results demonstrate the antiepileptogenic potential of P2X7R antagonism to prevent TBI-induced epilepsy and indicate that P2X7R-based PET imaging may be a useful diagnostic tool to identify people at risk of developing PTE.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
P2X7R拮抗剂抑制小鼠创伤性脑损伤后的长时间脑高兴奋性。
目的:创伤后癫痫(PTE)是创伤性脑损伤(TBI)后最常见的降低生活质量的后果之一。P2X7受体(P2X7R)是一种阳离子atp依赖性膜通道,在整个大脑中表达。虽然越来越多的证据表明P2X7R在癫痫发作和癫痫中起作用,但尚不清楚P2X7R表达的变化是否可以预测TBI诱导的癫痫发展,以及P2X7R拮抗剂是否可以防止TBI引起的长期脑高兴奋性。方法:采用控制性皮质冲击模型(CCI)诱导成年雄性小鼠脑外伤。为了测试P2X7R拮抗剂的抗癫痫作用,小鼠在cci后用脑渗透P2X7R拮抗剂JNJ-54175446 (30 mg/kg)或AFC-5128 (30 mg/kg)治疗7天。在小胶质细胞(P2rx7:Cx3cr1-Cre)缺乏P2rx7基因外显子2的小鼠中,分析了P2X7Rs对tbi诱导的高兴奋性的细胞类型特异性作用。在损伤后第1周和第3周,通过静脉注射P2X7R放射配体18F-JNJ-64413739进行静态正电子发射断层扫描(PET)和磁共振成像(MRI)。结果:脑外伤后,同侧海马P2X7R蛋白水平在损伤后无明显变化,但在损伤后3个月,同侧皮质P2X7R蛋白水平有延迟性升高。在TBI后不久使用P2X7R拮抗剂治疗可减少长期脑高兴奋性,减少皮质挫伤体积,并使损伤引起的多动正常化,以控制TBI后3周的假水平。值得注意的是,小胶质细胞中缺乏P2rx7的小鼠在TBI后癫痫发作阈值升高,这表明P2X7R通过对小胶质细胞的影响导致了大脑的高兴奋性。最后,TBI后P2X7R放射性配体摄取与损伤后3周的癫痫发作阈值相关。结论:我们的研究结果表明P2X7R拮抗剂具有预防tbi诱发癫痫的抗癫痫潜力,并表明基于P2X7R的PET成像可能是识别PTE高危人群的有用诊断工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Theranostics
Theranostics MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
25.40
自引率
1.60%
发文量
433
审稿时长
1 months
期刊介绍: Theranostics serves as a pivotal platform for the exchange of clinical and scientific insights within the diagnostic and therapeutic molecular and nanomedicine community, along with allied professions engaged in integrating molecular imaging and therapy. As a multidisciplinary journal, Theranostics showcases innovative research articles spanning fields such as in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensor technology, nanobiosensors, bioelectronics, system biology, translational medicine, point-of-care applications, and personalized medicine. Encouraging a broad spectrum of biomedical research with potential theranostic applications, the journal rigorously peer-reviews primary research, alongside publishing reviews, news, and commentary that aim to bridge the gap between the laboratory, clinic, and biotechnology industries.
期刊最新文献
Erratum: Macrophage membrane-functionalized nanotherapeutics for tumor targeted therapy: Erratum. Erratum: Mutation of SPINOPHILIN (PPP1R9B) found in human tumors promotes the tumorigenic and stemness properties of cells: Erratum. Cardiomyocyte-derived OTUD7B promotes cardiac hypertrophy by deubiquitinating SERCA2a. Epigenetic and O-glycosylation regulation of p66Shc mitigates mitochondrial oxidative stress in aortic dissection. MUC20 alleviates kidney fibrosis by modulating pyroptosis through the MET/RAS/STING axis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1